Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Gata6 is important for protecting hair growth cells from DNA damage and keeping normal hair growth.

Finasteride may help some women with hair loss, but better options exist.

5% minoxidil works better for hair growth than 1% minoxidil.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Finasteride capsules with nanoparticles improve drug delivery, solubility, stability, and effectiveness.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Children with trichotillomania often pull hair from their scalp, and parents may not notice; stress can trigger it, and asking detailed questions helps in diagnosis and treatment.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.